Jill P Buyon MD

Professor of Medicine, NYU School of Medicine

333 E 38th St# NyuNew York, NY 10016
Phone+1 646-501-7400
Fax+1 646-501-7228

Dr. Buyon is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Buyon's full profile Already have an account?

Education & Training

NYU Grossman School of MedicineFellowship, Rheumatology, 1981 - 1983
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1978 - 1981
Albert Einstein College of MedicineClass of 1978

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NJ State Medical License 1982 - Present
NY State Medical License 1979 - 2028
FL State Medical License 2016 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
America's Top Doctors Castle Connolly, 2002-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014

Clinical Trials

Safety of Estrogens in Lupus: Hormone Replacement Therapy
TERMINATED
PHASE3
Safety of Estrogens in Lupus: Birth Control Pills
COMPLETED
PHASE3
Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus
COMPLETED
NA

Publications & Presentations

PubMed

Age-specific Incidence of Systemic Lupus Erythematosus in the United States: A Meta-Analysis of Data from the Centers for Disease Control and Prevention Lupus Registries.
Peter M Izmirly, Elizabeth D Ferucci, Aimee O Hersh, Mary Beth Son, S Sam Lim
Arthritis & Rheumatology. 2026-08-24
A population-scale transcriptional atlas of blood and tissue in lupus nephritis.
Nicholas W Sugiarto, Siddarth Gurajala, Michelle Curtis, Thomas M Eisenhaure, Arnon Arazi
Science Translational Medicine. 2026-08-19
Correlation of Hydroxychloroquine Whole Blood Levels With Real and Ideal Body Weight Dosing and Development of Retinal Toxicity.
Alexis Kaiser, Joseph Colcombe, Lucy Cobbs, Emily Gutowski, Jill Buyon
Journal of Vitreoretinal Diseases. 2026-08-06

Journal Articles

The Prevention, Screening and Treatment of Congenital Heart Block from Neonatal Lupus: A Survey of Provider Practices
Matthew R Williams, Lisa R Sammaritano, Jill Buyon, Rheumatology
A Prospective International Study on Adherence to Treatment in 305 Patients with Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires
Peter Izmirly, Michelle Petri, Meenakshi Jolly, Jill Buyon, Clinical Pharmacology & Therapeutics

Lectures

CME Event - Clinical Advances in Lupus
Association of Black Cardiologists,Inc. (ABC), Detroit, Michigan - 4/13/2013
CME Event - Clinical Advances in Lupus
Association of Black Cardiologists,Inc. (ABC), Cincinnati, Ohio - 4/6/2013

Other

Tubulointerstitial Damage in Lupus Nephritis: A Comparison of the Factors Associated with Tubulointerstitial Inflammation and Renal Scarring
Jill Buyon, MD, Arthritis & Rheumatology
https://www.doximity.com/articles/17ea5c20-c7ef-4590-8eb8-a8d805417b8d
UpToDate, Wolters Kluwer Health - 2012-09-21

Press Mentions

New Drug Reduces Risk of Congenital Heart Block Recurrence in High-Risk PregnanciesOctober 22nd, 2025
Drug Prevents Congenital Heart Block Recurrence in a High-Risk PregnancyOctober 22nd, 2025
Lupus Linked with Greater Risk of Cardiovascular Complications of ChildbirthNovember 29th, 2022

Grant Support

Atrioventricular Block Elimination by Rozanolixizumab TreatmentNEW YORK UNIVERSITY SCHOOL OF MEDICINE2025–2030
Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus ErythematosusUNIVERSITY OF CHICAGO2026–2029
Digital Pathology and Computational Image Analysis for Lupus NephritisUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2029
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2028
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and HealthNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2027